“Two of your children have a fatal, untreatable disease - they are dying”   That is the news we received for two of our beautiful daughters, Kinley (7) and Kennedy (4), the morning after our third daughter, Kieran, was born.   Without warning, we were faced with the sobering realization that our baby girls are dying.  Before this disease takes them, Kinley and Kennedy will very slowly lose their ability to walk, talk, eat…and even smile. We have been on a 4 year journey trying to understand what might be causing the developmental delays Kinley has been experiencing.  After countless appointments and evaluations with specialists from nearly every medical field, we finally received our answer on June 5th 2020 - the one we never saw coming. A full genetic screening revealed that not only Kinley, but her younger sister Kennedy both have an extremely rare genetic disorder called GM1 Gangliosidosis.  We are forever thankful that baby Kieran is not affected by this wretched disease.  Currently, there is no approved treatment or cure for GM1, and it is always fatal in children. ******** OUR NEW REALITY GM1 Gangliosidosis is an aggressive disease where the body does not produce adequate enzymes to break down certain molecules. Instead, these molecules collect on the brain and spinal cord, leading to widespread neurodegeneration. The list of complications that our girls face is truly terrifying and the idea of watching them slowly fade away is our worst nightmare.  Right now, Kinley and Kennedy are in a relatively “stable” state in their disease progression.  They can still walk independently and are verbal, though both are experiencing speech issues that make them hard to understand.  Looking at them, one would never know they both face such a grave fate, but there will come a day where each of them will no longer be able to run outside with their friends, jump on their trampoline, or tell their baby sister “I love you” if no treatments are developed.    Kinley, who wants nothing more than to be a doctor, nurse, or vet so she can help other people, will eventually not be able to take care of herself independently.   Kennedy, who loves to dance and sing and dress up, will someday not be able to do her infamous twirls and leaps, or “freeze” you with her Elsa powers. Each morning, we wake to the reality that we are another day closer to that outcome.  One day, they won’t recognize their mom and dad.  One day, they won’t be able to tell us they need something, or that they love us.  One day, they will require a feeding tube.  One day,  we will lay two of our precious babies to rest. Life expectancy for the type of GM1 Kinley and Kennedy have is difficult to predict, but estimates range anywhere from mid-childhood (10-15 years old) to the early twenties.  We are hopeful that both Kinley and Kennedy have many more great years ahead of them at a quality of life that they both deserve.   There is no way to know at what point the disease will firm its grip on Kinley and Kennedy - we are in a race against time. <img src="https://d2g8igdw686xgo.cloudfront.net/49113456_1593782161583825_r.jpeg" alt="49113456_1593782161583825_r.jpeg" width="100%" media_type="3" /> SOME HOPE - IT'S NOT TOO LATE There are several treatment clinical trials coming up for both substrate suppression therapy and gene therapy through drug companies, universities, and the NIH.  This Page is a mission of hope for our family and others impacted by GM1 Gangliosidosis, and provides support to ensure these trials and developments continue. We are committed to raising awareness of this horrid disease, and promoting funding for continued research and the advancement of current clinical trials that may eventually be accessible to these children, including our own.  In fact, some believe a cure is imminent - it simply needs the support and dollars to advance.  We are not naive to the fact, however, that clinical trial spots are very, very limited and are experimental, so there are never guarantees...but we do know that our girls do not need to suffer! We intend to soak in every moment with Kinley and Kennedy while they can still run, dance, sing, and just be kids.  We now know how precious each and every day is, and appreciate every time we hear the words “I love you” from them, or hear them sing lullabies to their baby sister.  While continuing to give our girls all the love we can, and show them the world as best we can, we simply must fight to find off-label treatments to slow the progression long enough for a cure to be developed. We will still show them the world, provide experiences even seasoned adults have never had, and make sure every moment they have on this earth is not taken for granted.  <img src="https://d2g8igdw686xgo.cloudfront.net/49113456_1593782329575594_r.jpeg" alt="49113456_1593782329575594_r.jpeg" width="100%" media_type="3" /><img src="https://d2g8igdw686xgo.cloudfront.net/49113456_15937823484403_r.jpeg" alt="49113456_15937823484403_r.jpeg" width="100%" media_type="3" /> OUR GOAL Developing treatments in the United States is notoriously expensive.  For gene therapy specifically, it is estimated to cost between $1,000,000 and $2,000,000 for a single clinical trial participant*.   We are raising $2,000,000 - the conservative estimate for both Kinley and Kennedy to participate in a gene therapy trial.  We refuse to sit idly while our babies bodies slowly betray them and we can only achieve this goal with your support.  Every dollar is immensely important, and sharing the information with your network can and will work miracles.  Reaching this goal won’t guarantee Kinley and Kennedy treatment, but it will go far in advancing the development of the cures we and families in our position so desperately desire. We all say “we will do anything for our children”.  We’re asking for you to help us in this journey so our children and other families in our position can retain hope that there is a better future for our babies. SPECIFIC WAYS TO HELP 1)  If you’re in a position to do so, please consider a donation.  Every dollar counts. 2)  Spread the word - share to your social networks, email the GoFundMe information to anyone you know, and be sure to ask if your company has a donation matching program!   <a href="http://www.curekinleyandkennedy.org">www.curekinleyandkennedy.org</a>  3)  AmazonSmiles - if you aren’t already supporting a charity of choice, please take a moment to update your AmazonSmiles beneficiary to Cure GM1 Foundation.  After that, shop as you normally do, and a donation will automatically be provided for each dollar spent.   <a href="https://www.amazon.com/gp/help/customer/display.html?nodeId=202029360"><a href="https://www.amazon.com/gp/help/customer/display.html?nodeId=202029360" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.amazon.com/gp/help/customer/display.html?nodeId=202029360</a></a>  4)  Forward any leads you may have to support our cause to our Facebook Page or our email address:   <a href="https://www.facebook.com/CureKinleyKennedy"><a href="https://www.facebook.com/CureKinleyKennedy" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.facebook.com/CureKinleyKennedy</a></a>  <a href="mailto:[email redacted]">[email redacted]</a>  WHERE IS THE MONEY GOING? Every dollar will benefit the <a href="https://curegm1.org" target="_blank" rel="noreferrer noopener">Cure GM1 Foundation</a>, a 501(c)(3) nonprofit organization whose mission is to advance the development of life-saving treatments for GM1.   The Cure GM1 Foundation is currently funding a next generation gene therapy program in collaboration with a world class research team.  The team is headed by Dr. Krystof Bankiewicz at Ohio State University who works in close collaboration with Children's Nationwide Hospital in Columbus, Ohio.  Other initiatives include funding research studies to further drug development, newborn screening, and increasing overall awareness. All donations are 100% tax deductible!  <img src="https://d2g8igdw686xgo.cloudfront.net/49113456_1593782564458707_r.jpeg" alt="49113456_1593782564458707_r.jpeg" width="100%" media_type="3" /> *“Novel Financing Approaches Are Needed to Capitalize on Life-Saving Gene Therapies∗.” The American Consumer, The American Consumer Institute Center for Citizen Research, <a href="http://www.theamericanconsumer.org/wp-content/uploads/2019/02/Gene-Therapy-FINAL.pdf">www.theamericanconsumer.org/wp-content/uploads/2019/02/Gene-Therapy-FINAL.pdf</a>. Accessed 1 June 2020.

Anonymous

James MacKinnon

Amri Dobbins

Jeremy Stieben

Sarah Magnino

Sheila Scarcliff

Jessica Tower

Debbie Rankin

Kraig Lothe

Cure Kinley & Kennedy (via Cure GM1 Foundation)

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

Eligible for Profile Share Badge

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

isEligibleForProfileBadge

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.3.0 and above

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Cure Kinley & Kennedy (via Cure GM1 Foundation)

Still $1,668,887 to go. Help us build momentum.